The Merlin team had a very successful plenary in Rotterdam on 10 and 11 May. Updates were presented on each WP. MSC production and preparation for the upcoming trial were naturally a key focus at this stage of the project. Publications and plans for future work were also discussed. Many thanks to EMC for hosting and to all the partners for their input into a very productive and enjoyable meeting!
- Cells cultured in vitro have the same biological characteristics as the functional cells that line the bile duct t.co/oFyJoVhH0A Time ago 7 Days via Twitter Web Client
- Here is an interesting new text from the leaders of the Stromal Immunology Group: t.co/8kupRloqoF @stromalimmune Time ago 8 Days via Twitter Web Client
- @PSCSupportUK wants to see a world without Primary Sclerosing Cholangitis. #PSC is a rare autoimmune disease of the… t.co/gEqQtgEbCP Time ago 12 Days via Twitter Web Client
Follow @fp7merlin on twitter.
This project has received funding from the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement no 602363. The material presented and views expressed here are the responsibility of the author(s) only. The EU Commission takes no responsibility for any use made of the information set out.